Stock Price
4.17
Daily Change
0.04 0.97%
Monthly
16.16%
Yearly
136.93%
Q2 Forecast
4.07

EDAP TMS reported EUR49K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AngioDynamics USD 102K 2K Sep/2025
Boston Scientific USD 90M 0 Mar/2026
EDAP TMS EUR 49K 8K Sep/2025
Henry Schein USD 39M 0 Mar/2026
Medtronic USD 181M 0 Dec/2025
Plus Therapeutics USD 62K 25K Dec/2023
Veracyte USD 2K 1000 Dec/2023